- Home
- CLRB vs TNON Comparison
CLRB vs TNON Comparison
Compare CLRB & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- TNON
- Stock Information
- Founded
- CLRB 2002
- TNON 2012
- Country
- CLRB United States
- TNON United States
- Employees
- CLRB N/A
- TNON N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- TNON Medical Specialities
- Sector
- CLRB Health Care
- TNON Health Care
- Exchange
- CLRB Nasdaq
- TNON Nasdaq
- Market Cap
- CLRB 14.2M
- TNON 11.5M
- IPO Year
- CLRB N/A
- TNON 2022
- Fundamental
- Price
- CLRB $4.98
- TNON $1.15
- Analyst Decision
- CLRB Hold
- TNON Strong Buy
- Analyst Count
- CLRB 2
- TNON 2
- Target Price
- CLRB N/A
- TNON $5.50
- AVG Volume (30 Days)
- CLRB 154.8K
- TNON 758.9K
- Earning Date
- CLRB 08-14-2025
- TNON 08-13-2025
- Dividend Yield
- CLRB N/A
- TNON N/A
- EPS Growth
- CLRB N/A
- TNON N/A
- EPS
- CLRB N/A
- TNON N/A
- Revenue
- CLRB N/A
- TNON $2,947,000.00
- Revenue This Year
- CLRB N/A
- TNON $43.52
- Revenue Next Year
- CLRB N/A
- TNON $82.14
- P/E Ratio
- CLRB N/A
- TNON N/A
- Revenue Growth
- CLRB N/A
- TNON N/A
- 52 Week Low
- CLRB $4.11
- TNON $0.85
- 52 Week High
- CLRB $67.50
- TNON $15.79
- Technical
- Relative Strength Index (RSI)
- CLRB 51.74
- TNON 39.28
- Support Level
- CLRB $4.43
- TNON $1.36
- Resistance Level
- CLRB $5.08
- TNON $1.57
- Average True Range (ATR)
- CLRB 0.40
- TNON 0.08
- MACD
- CLRB 0.10
- TNON -0.04
- Stochastic Oscillator
- CLRB 73.11
- TNON 8.64
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.